Selected research
Industry Research
Encephalitis Vaccine Industry Research Report 2026
Market perspective
The global Encephalitis Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Encephalitis Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Encephalitis Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Encephalitis Vaccine include Biken, Valneva, Tiantan Biological Products, Chengdu Institute of Biological Products, Lanzhou Institute of Biological Products, Liaoning Chengda, Sanofi Pasteur, Wuhan Institute of Biological Products and Yisheng Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Encephalitis Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Encephalitis Vaccine Market by Company
Biken
Valneva
Tiantan Biological Products
Chengdu Institute of Biological Products
Lanzhou Institute of Biological Products
Liaoning Chengda
Sanofi Pasteur
Wuhan Institute of Biological Products
Yisheng Bio
Changchun Institute of Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Encephalitis Vaccine Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Encephalitis Vaccine Segment by Application
Child
Adult
Encephalitis Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encephalitis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Encephalitis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Encephalitis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Encephalitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inactivated Vaccine
- Live Attenuated Vaccine
Applications
- Child
- Adult
Companies covered
- Biken
- Valneva
- Tiantan Biological Products
- Chengdu Institute of Biological Products
- Lanzhou Institute of Biological Products
- Liaoning Chengda
- Sanofi Pasteur
- Wuhan Institute of Biological Products
- Yisheng Bio
- Changchun Institute of Biological Products
- Zhejiang Tianyuan Bio-Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Encephalitis Vaccine Market Size (2021-2032)
- 2.2.2 Global Encephalitis Vaccine Sales (2021-2032)
- 2.2.3 Global Encephalitis Vaccine Market Average Price (2021-2032)
- 2.3 Encephalitis Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inactivated Vaccine
- 2.3.3 Live Attenuated Vaccine
- 2.4 Encephalitis Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Child
- 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Encephalitis Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Encephalitis Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Encephalitis Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Encephalitis Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Encephalitis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Encephalitis Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Encephalitis Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Encephalitis Vaccine, Established Date
- 3.9 Global Encephalitis Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Biken
- 4.1.1 Biken Company Information
- 4.1.2 Biken Business Overview
- 4.1.3 Biken Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Biken Encephalitis Vaccine Product Portfolio
- 4.1.5 Biken Recent Developments
- 4.2 Valneva
- 4.2.1 Valneva Company Information
- 4.2.2 Valneva Business Overview
- 4.2.3 Valneva Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Valneva Encephalitis Vaccine Product Portfolio
- 4.2.5 Valneva Recent Developments
- 4.3 Tiantan Biological Products
- 4.3.1 Tiantan Biological Products Company Information
- 4.3.2 Tiantan Biological Products Business Overview
- 4.3.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Tiantan Biological Products Encephalitis Vaccine Product Portfolio
- 4.3.5 Tiantan Biological Products Recent Developments
- 4.4 Chengdu Institute of Biological Products
- 4.4.1 Chengdu Institute of Biological Products Company Information
- 4.4.2 Chengdu Institute of Biological Products Business Overview
- 4.4.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolio
- 4.4.5 Chengdu Institute of Biological Products Recent Developments
- 4.5 Lanzhou Institute of Biological Products
- 4.5.1 Lanzhou Institute of Biological Products Company Information
- 4.5.2 Lanzhou Institute of Biological Products Business Overview
- 4.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolio
- 4.5.5 Lanzhou Institute of Biological Products Recent Developments
- 4.6 Liaoning Chengda
- 4.6.1 Liaoning Chengda Company Information
- 4.6.2 Liaoning Chengda Business Overview
- 4.6.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Liaoning Chengda Encephalitis Vaccine Product Portfolio
- 4.6.5 Liaoning Chengda Recent Developments
- 4.7 Sanofi Pasteur
- 4.7.1 Sanofi Pasteur Company Information
- 4.7.2 Sanofi Pasteur Business Overview
- 4.7.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Pasteur Encephalitis Vaccine Product Portfolio
- 4.7.5 Sanofi Pasteur Recent Developments
- 4.8 Wuhan Institute of Biological Products
- 4.8.1 Wuhan Institute of Biological Products Company Information
- 4.8.2 Wuhan Institute of Biological Products Business Overview
- 4.8.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolio
- 4.8.5 Wuhan Institute of Biological Products Recent Developments
- 4.9 Yisheng Bio
- 4.9.1 Yisheng Bio Company Information
- 4.9.2 Yisheng Bio Business Overview
- 4.9.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yisheng Bio Encephalitis Vaccine Product Portfolio
- 4.9.5 Yisheng Bio Recent Developments
- 4.10 Changchun Institute of Biological Products
- 4.10.1 Changchun Institute of Biological Products Company Information
- 4.10.2 Changchun Institute of Biological Products Business Overview
- 4.10.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolio
- 4.10.5 Changchun Institute of Biological Products Recent Developments
- 4.11 Zhejiang Tianyuan Bio-Pharmaceutical
- 4.11.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
- 4.11.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
- 4.11.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolio
- 4.11.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
5 Global Encephalitis Vaccine Market Scenario by Region
- 5.1 Global Encephalitis Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Encephalitis Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Encephalitis Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Encephalitis Vaccine Sales by Region: 2027-2032
- 5.3 Global Encephalitis Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Encephalitis Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Encephalitis Vaccine Revenue by Region: 2027-2032
- 5.4 North America Encephalitis Vaccine Market Facts & Figures by Country
- 5.4.1 North America Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Encephalitis Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Encephalitis Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Encephalitis Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Encephalitis Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Encephalitis Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Encephalitis Vaccine Market Facts & Figures by Country
- 5.7.1 South America Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Encephalitis Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Encephalitis Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Encephalitis Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Encephalitis Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Encephalitis Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Encephalitis Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Encephalitis Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Encephalitis Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Encephalitis Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Encephalitis Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Encephalitis Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Encephalitis Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Encephalitis Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Encephalitis Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Encephalitis Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Encephalitis Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Encephalitis Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Encephalitis Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Encephalitis Vaccine Value Chain Analysis
- 8.1.1 Encephalitis Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Encephalitis Vaccine Production Mode & Process
- 8.2 Encephalitis Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Encephalitis Vaccine Distributors
- 8.2.3 Encephalitis Vaccine Customers
9 Global Encephalitis Vaccine Analyzing Market Dynamics
- 9.1 Encephalitis Vaccine Industry Trends
- 9.2 Encephalitis Vaccine Industry Drivers
- 9.3 Encephalitis Vaccine Industry Opportunities and Challenges
- 9.4 Encephalitis Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst